Reveal for Arrhythmias

Accelerated arrhythmia detection that meets you where you are

Accelerate Detection. Empower Your Teams. Transform Outcomes.

Reveal for Arrhythmias identifies cardiac risk in high-volume, high-need populations, without burdening your staff or workflows.

Help patients get the right care sooner, with proactive, AI-driven disease detection that meets your organization where it is today… while supporting your quality, efficiency and value-based care goals.

Accelerate Detection. Empower Your Teams. Transform Outcomes.

Reveal for Arrhythmias identifies cardiac risk in high-volume, high-need populations, without burdening your staff or workflows.

Help patients get the right care sooner, with proactive, AI-driven disease detection that meets your organization where it is today… while supporting your quality, efficiency and value-based care goals.

How Reveal for Arrhythmias Works

Reveal for Arrhythmias brings early arrhythmia detection into focus, designed to support the way your team already operates.

Advanced AI Analysis

Reveal examines existing patient records for subtle indicators of arrhythmia risk, prioritizing the populations most prone to undiagnosed issues.

Seamless Workflow Integration

Cases of elevated risk are flagged directly in existing systems for review and outreach.

Streamlined Monitoring Pathway

For flagged patients, Reveal enables easy referral for effective ambulatory cardiac monitoring using iRhythm’s trusted Zio device.

Actionable Results

Diagnose arrhythmias sooner, fast-track intervention, and improve patient outcomes while reducing downstream costs.

Enabling Clinical Efficiency & Performance

Reveal for Arrhythmias Work List_App Detail-1

AI-Powered Precision: Reveal analyzes your existing clinical and EHR data to flag hidden cardiac arrhythmia risk in populations prone to being overlooked, such as those with Type 2 diabetes, chronic kidney disease (CKD), COPD, or coronary artery disease.

No Additional Staffing Required: Reveal integrates into your current systems and workflows, helping you identify and manage at-risk patients without increasing demand on clinical teams.

Proactive, Not Reactive: Uncover silent arrhythmias before they become costly emergencies, enabling earlier intervention, improved outcomes, and more predictable resource use.

Designed for Value-Based Care: Reveal empowers at-risk provider groups, ACOs, payviders, and health systems to move from episodic care toward scalable, preventive health management—improving outcomes and cost-efficiency.

Enabling Clinical Efficiency & Performance

AI-Powered Precision: Reveal analyzes your existing clinical and EHR data to flag hidden cardiac arrhythmia risk in populations prone to being overlooked, such as those with Type 2 diabetes, chronic kidney disease (CKD), COPD, or coronary artery disease.

No Additional Staffing Required: Reveal integrates into your current systems and workflows, helping you identify and manage at-risk patients without increasing demand on clinical teams.

Proactive, Not Reactive: Uncover silent arrhythmias before they become costly emergencies, enabling earlier intervention, improved outcomes, and more predictable resource use.

Designed for Value-Based Care: Reveal empowers at-risk provider groups, ACOs, payviders, and health systems to move from episodic care toward scalable, preventive health management—improving outcomes and cost-efficiency.

Powering the Next Generation of Preventive Cardiac Care

Reveal for Arrhythmias is powered by Lucem Health’s advanced AI and analytics, and enhanced through a unique partnership with iRhythm Technologies—leaders in cardiac monitoring.

End-to-end risk to diagnosis pathway: Reveal pinpoints patients at risk; iRhythm’s proven Zio technology confirms arrhythmias.
Innovation at scale: Our partnership combines predictive data science with clinical-grade diagnostics, making early detection seamless and scalable for all types of healthcare organizations.
Shared commitment: Both Lucem Health and iRhythm are dedicated to enabling efficient, proactive, and equitable access to advanced care for millions.

Powering the Next Generation of Preventive Cardiac Care

Reveal for Arrhythmias is powered by Lucem Health’s advanced AI and analytics, and enhanced through a unique partnership with iRhythm Technologies—leaders in cardiac monitoring.

End-to-end risk to diagnosis pathway: Reveal pinpoints patients at risk; iRhythm’s proven Zio technology confirms arrhythmias.
Innovation at scale: Our partnership combines predictive data science with clinical-grade diagnostics, making early detection seamless and scalable for all types of healthcare organizations.
Shared commitment: Both Lucem Health and iRhythm are dedicated to enabling efficient, proactive, and equitable access to advanced care for millions.

The Proactive Care Imperative

The need to detect and diagnose arrhythmias earlier has never been greater. Rising rates of chronic illness and escalating healthcare costs mean that finding heart rhythm issues early is no longer optional, it’s essential. Today, the stakes are higher, the impact more immediate, and the need for action more critical than ever before.

A large number of Americans could benefit from proactive arrhythmia detection today¹

2x higher hospitalization rates for Type 2 diabetes or COPD patients with undetected arrhythmias²

$16,000 in annual savings for monitored vs. unmonitored high-risk patients³

Early Detection Saves Lives

Contact Lucem Health to see how Reveal for Arrhythmias can help your organization identify risk, drive efficiency, and deliver world-class care—without added complexity.

Get In Touch